bring down the out of pocket cost on medication
Bring down out-of-pocket medication costs.
Occurrences
Evidence
"I will work hard to protect and strengthen the ACA, increase the flexibility of Medicaid dollars so that states like Washington can continue expanding coverage, bring down the out of pocket cost on medication, and invest in staffing critical healthcare positions and infrastructure so people have more than just theoretical access to the care they need."
The House passed a three-year extension of the Affordable Care Act enhanced premium tax credits, and Randall said the expired credits were forcing millions to face "huge increases" in their 2026 premiums or forgo coverage entirely due to rising costs.
Congress.gov lists Randall's member activity, including sponsored and cosponsored legislation and 282 House roll call votes in the 119th Congress; her activity page shows multiple health-related bills and floor votes but no enacted drug-cost measure identified there.
Randall said the 2024 session accomplishments included bills she sponsored and other measures focused on affordability and health care access, reflecting an established record of pursuing lower-cost care before her congressional term.
Assessments
Randall explicitly promised to lower out-of-pocket medication costs, but the evidence provided does not show that she delivered a completed federal medication-cost reduction measure. The strongest same-term accomplishment tied to affordability is her support for extending ACA premium tax credits, which helps reduce health-care costs for consumers but is not medication-specific. Her congressional activity and prior state-level health affordability work show meaningful effort and related action, so this is more than unresolved, but the record here falls short of full delivery on the narrower prescription-cost promise.
The promise specifically concerned lowering out-of-pocket medication costs. The evidence shows Randall advocated and voted on broader health-care affordability measures, including ACA premium tax credit extension, and had health-related legislative activity, but no enacted federal measure or completed action is identified that clearly reduced patients' out-of-pocket prescription medication costs. Because there was meaningful related legislative effort but the promised medication-cost outcome was not delivered, this is classified as not fulfilled with an effort badge.